Language Select
Varian Logo

Varian Acquires Embolic Bead Assets from Boston Scientific

We are pleased to announce that, on August 19, 2019, Varian closed its acquisition of Boston Scientific’s portfolio of microsphere (Oncozene/Embozene Tandem) and bland embolic (Embozene) bead products.

These products are part of a growing interventional oncology product portfolio Varian has been assembling, starting with the previous acquisition of Endocare® cryoablation and MicroThermX® microwave ablation systems.  Varian is deeply committed to the ongoing development of innovative treatment offerings and to helping advance the field of interventional oncology as an important pillar of patient care.

More product details:

United States

CE Mark Countries

To read more about Varian’s new cryoablation and microwave ablation products:

Endocare ® cryoablation systems and disposables. Cryoablation can be used for a wide variety of indications under CT guidance. Cryoablation is a minimally invasive treatment option for prostate, kidney, and lung cancers as well as liver metastases. In addition, freezing of nerves can help with pain management.

MicroThermX® microwave ablation, a one-of-a-kind system that offers a unique balance of precise control, flexibility, and power in delivering microwave energy for coagulation (ablation) of soft tissue.

Contact Us

Customer Service: 1-877-467-2009 or .

Calendar of Interventional Oncology Events

Visit the Varian booth at these upcoming events:

Sept 7-11


Barcelona, Spain

Sept 13-15

6th Annual Symposium on Academic Interventional Radiology

Washington DC, USA

Sept 15-19

(WAIS) Western Angio

Napa, CA, USA

Oct 11-13

(CIO) Clinical Interventional Oncology

Miami, FL, USA

Oct 16 – 19

DDI - Digestive Disease Interventions

New York, NY, USA

Nov 19

AIM - Advanced Interventional Management

New York, NY, USA

Dec 1-6


Chicago, IL, USA